E-resources
-
Pierobon, Mariaelena; Ramos, Corinne; Wong, Shukmei; Hodge, K Alex; Aldrich, Jessica; Byron, Sara; Anthony, Stephen P; Robert, Nicholas J; Northfelt, Donald W; Jahanzeb, Mohammad; Vocila, Linda; Wulfkuhle, Julia; Gambara, Guido; Gallagher, Rosa I; Dunetz, Bryant; Hoke, Nicholas; Dong, Ting; Craig, David W; Cristofanilli, Massimo; Leyland-Jones, Brian; Liotta, Lance A; O'Shaughnessy, Joyce A; Carpten, John D; Petricoin, Emanuel F
Clinical cancer research, 08/2017, Volume: 23, Issue: 16Journal Article
Little is known about the molecular signatures associated with specific metastatic sites in breast cancer. Using comprehensive multi-omic molecular profiling, we assessed whether alterations or activation of the PI3K-AKT-mTOR pathway is associated with specific sites of breast cancer metastasis. Next-generation sequencing-based whole-exome sequencing was coupled with reverse-phase protein microarray (RPPA) functional signaling network analysis to explore the PI3K-AKT-mTOR axis in 32 pretreated breast cancer metastases. RPPA-based signaling data were further validated in an independent cohort of 154 metastatic lesions from breast cancer and 101 unmatched primary breast tumors. The proportion of cases with PI3K-AKT-mTOR genomic alterations or signaling network activation were compared between hepatic and nonhepatic lesions. mutation and activation of AKT (S473) and p70S6K (T389) were detected more frequently among liver metastases than nonhepatic lesions ( < 0.01, = 0.056, and = 0.053, respectively). However, mutations alone were insufficient in predicting protein activation ( = 0.32 and = 0.19 for activated AKT and p70S6K, respectively). RPPA analysis of an independent cohort of 154 tumors confirmed the relationship between pathway activation and hepatic metastasis AKT (S473), mTOR (S2448), and 4EBP1 (S65); < 0.01, = 0.02, and = 0.01, respectively. Similar results were also seen between liver metastases and primary breast tumors AKT (S473) < 0.01, mTOR (S2448) < 0.01, 4EBP1 (S65) = 0.01. This signature was lost when primary tumors were compared with all metastatic sites combined. Breast cancer patients with liver metastasis may represent a molecularly homogenized cohort with increased incidence of mutations and activation of the PI3K-AKT-mTOR signaling network. .
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.